Non-interventional Surveillance of Effectiveness of Symbicort® Maintenance And Reliever Therapy (Symbicort® SMART) in the Treatment of Moderate and Severe Asthma

• Register: ClinicalTrials.gov
• Last refreshed on: 19 February 2015
• Main ID: NCT00573222
• Date of registration: 13/12/2007
• Prospective Registration: No
• Primary sponsor: AstraZeneca
• Public title: Non-interventional Surveillance of Effectiveness of Symbicort® Maintenance And Reliever Therapy (Symbicort® SMART) in the Treatment of Moderate and Severe Asthma
• Scientific title: Non-interventional Surveillance of Effectiveness of Symbicort® Maintenance And Reliever Therapy (Symbicort® SMART) in the Treatment of Moderate and Severe Asthma
• Date of first enrolment: November 2007
• Target sample size: 330
• Recruitment status: Completed
• URL: http://clinicaltrials.gov/show/NCT00573222
• Study type: Observational
• Study design: Time Perspective: Prospective
• Phase: N/A

Countries of recruitment

Croatia

Contacts

• Name: Anan Marija Gjurovic
• Affiliation: AstraZeneca

Key inclusion & exclusion criteria

Inclusion Criteria:

- Patients with moderate and severe asthma on Symbicort SMART treatment

Exclusion Criteria:

- Under 18 years old



Age minimum: 18 Years
Age maximum: N/A
Gender: Both

Health Condition(s) or Problem(s) studied

Asthma

Intervention(s)

Drug: Symbicort

Primary Outcome(s)

To evaluate & describe asthma control in adult patients w/moderate to severe asthma treated w/Symbicort SMART following the frequency, type & severity of symptoms through the Asthma Control Questionnaire.

Secondary Outcome(s)

to evaluate the safety of Symbicort SMART treatment through the number and type of reported adverse events 2. assessment of patient's satisfaction with the treatment 3.assessment of physician's satisfaction with the treatment

Secondary ID(s)

NIS-RHR-SYM-2007/1

Source(s) of Monetary Support

Please refer to primary and secondary sponsors